Published Papers & Misc - YAMAMOTO Kouhei

101. Konstantinou K, Yamamoto K, Ishibashi F, Mizoguchi Y, Kurata M, Nakagawa Y, Suzuki K, Sawabe M, Ohta M, Miyakoshi S, Crawley JT, Kitagawa M.. Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma. Br J Haematol.. 2009.03; 144 (5): 696-704. ( PubMed, DOI )

102. Shiraishi J, Nakagawa Y, Kurata M, Yamamoto K, Abe Y, Toyoda Y, Suzuki K, Kitagawa M, Takemura T.. Follicular lymphoma with marked infiltration of eosinophils. Pathol Int.. 2008.11; 58 (11): 701-705.

103. Kurata M, Nakagawa Y, Yamamoto K, Suzuki K, Kitagawa M.. Induction of integrin beta1 expression in bone marrow cells after chemotherapy correlates with the overexpression of lung resistance protein and poor outcome in patients with multiple myeloma. Am J Hematol.. 2008.09; 83 (9): 755-757. ( PubMed, DOI )

104. Karube K, Aoki R, Nomura Y, Yamamoto K, Shimizu K, Yoshida S, Komatani H, Sugita Y, Ohshima K.. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases. Pathol Int.. 2008.02; 58 (2): 89-97.

105. Shimizu K, Karube K, Arakawa F, Nomura Y, Komatani H, Yamamoto K, Yoshida S, Aoki R, Sugita Y, Takeshita M, Ohshima K.. Upregulation of CC chemokine ligand 18 and downregulation of CX3C chemokine receptor 1 expression in human T-cell leukemia virus type 1-associated lymph node lesions: Results of chemokine and chemokine receptor DNA chip analysis. Cancer Sci.. 2007.12; 98 (12): 1875-1850. ( PubMed )

106. Abe S, Hasegawa M, Yamamoto K, Kurata M, Nakagawa Y, Suzuki K, Takizawa T, Kitagawa M.. Rapid induction of IAP family proteins and Smac/DIABLO expression after proapoptotic stimulation with doxorubicin in RPMI 8226 multiple myeloma cells. Exp Mol Pathol.. 2007.12; 83 (3): 405-412. ( PubMed )

107. Keith T, Araki Y, Ohyagi M, Hasegawa M, Yamamoto K, Kurata M, Nakagawa Y, Suzuki K, Kitagawa M.. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia. Br J Haematol.. 2007.05; 137 (3): 206-215. ( PubMed )

108. Karube K, Guo Y, Suzumiya J, Sugita Y, Nomura Y, Yamamoto K, Shimizu K, Yoshida S, Komatani H, Takeshita M, Kikuchi M, Nakamura N, Takasu O, Arakawa F, Tagawa H, Seto M, Ohshima K.. CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood.. 2007.04; 109 (7): 3076-3079.

109. Kurata M, Hasegawa M, Nakagawa Y, Abe S, Yamamoto K, Suzuki K, Kitagawa M.. Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes. Exp Mol Pathol.. 2006.12; 81 (3): 249-254.

110. Nakagawa Y, Abe S, Kurata M, Hasegawa M, Yamamoto K, Inoue M, Takemura T, Suzuki K, Kitagawa M.. IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes. Am J Hematol.. 2006.12; 81 (11): 824-831.

111. Tamura K, Aoyagi M, Wakimoto H, Tamaki M, Yamamoto K, Yamamoto M, Ohno K.. Malignant transformation eight years after removal of a benign epidermoid cyst: a case report. J Neurooncol.. 2006.08; 79 (1): 67-72.

112. Kitagawa M, Utsuyama M, Kurata M, Yamamoto K, Yuasa Y, Ishikawa Y, Arai T, Hirokawa K.. Cancer and aging: symposium of the 27th annual meeting of the Japanese society for biomedical gerontology, Tokyo. Cancer Immunol Immunother.. 2005.07; 54 (7): 623-634.

113. Nakagawa Y, Hasegawa M, Kurata M, Yamamoto K, Abe S, Inoue M, Takemura T, Hirokawa K, Suzuki K, Kitagawa M.. Expression of IAP-family proteins in adult acute mixed lineage leukemia (AMLL). Am J Hematol.. 2005.03; 78 (3): 173-180.

114. Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia. Leukemia Research. 2004.11;